Immunoprecise Antibodies Ltd(IPA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IPA Immunoprecise Antibodies Ltd

Market Closed 07-05 16:00:00 EDT

1.00

+0.00

0.00%

盘后1.04

+0.04+4.00%

19:52 EDT

High1.02	Low0.9799	Vol129.73K
Open1.00	D1 Closing1.00	Amplitude3.96%
Mkt Cap26.32M	Tradable Cap22.79M	Total Shares26.32M
T/O129.32K	T/O Rate0.57%	Tradable Shares22.79M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"IPA","market":"US","secType":"STK","nameCN":"Immunoprecise Antibodies Ltd","latestPrice":1,"timestamp":1720209600000,"preClose":1,"halted":0,"volume":129726,"hourTrading":{"tag":"盘后","latestPrice":1.04,"preClose":1,"latestTime":"19:52 EDT","volume":3000,"amount":3120,"timestamp":1720223525305},"delay":0,"floatShares":22793072,"shares":26315260,"eps":-0.42246,"marketStatus":"Market Closed","change":0,"latestTime":"07-05 16:00:00 EDT","open":1,"high":1.0195,"low":0.9799,"amount":129324.1347972,"amplitude":0.0396,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.42246,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1720425600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1,"preHourTrading":{"tag":"盘前","latestPrice":0.9996,"preClose":1.01,"latestTime":"08:41 EDT","volume":356,"amount":358.9376052,"timestamp":1720183300587},"postHourTrading":{"tag":"盘后","latestPrice":1.04,"preClose":1,"latestTime":"19:52 EDT","volume":3000,"amount":3120,"timestamp":1720223525305},"volumeRatio":3.5241096593295707,"impliedVol":3.206,"impliedVolPercentile":0.9921},"requestUrl":"/m/hq/s/IPA","defaultTab":"news","newsList":[{"id":"2446532892","title":"BRIEF-Immunoprecise Appoints Kristin Taylor As Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2446532892","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446532892?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:47","pubTimestamp":1719492432,"startTime":"0","endTime":"0","summary":"June 27 (Reuters) - Immunoprecise Antibodies Ltd :   * IMMUNOPRECISE APPOINTS KRISTIN TAYLOR AS CHIEF FINANCIAL OFFICERSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2446532668","title":"ImmunoPrecise Names Kristin Taylor as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2446532668","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446532668?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:39","pubTimestamp":1719491963,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies Ltd. has appointed Kristin Taylor as their permanent Chief Financia...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immunoprecise-names-kristin-taylor-as-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immunoprecise-names-kristin-taylor-as-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2446534250","title":"ImmunoPrecise appoints Kristin Taylor as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2446534250","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446534250?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:25","pubTimestamp":1719491137,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (NASDAQ:IPA) Thursday announced the appointment of Kristin Taylor as Chief Financial Officer, effective immediately.\nTaylor has been serving as Interim CFO since September 19, 2023, and now transitions into the role on a permanent basis. Source: Press Release","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4119990-immunoprecise-appoints-kristin-taylor-as-cfo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["IPA","BK4121","SQQQ","NQmain","QID","TQQQ","QQQ","MNQmain",".IXIC","QLD","PSQ"],"gpt_icon":0},{"id":"2446553531","title":"ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2446553531","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446553531?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:01","pubTimestamp":1719489660,"startTime":"0","endTime":"0","summary":"VICTORIA, British Columbia, June 27, 2024----ImmunoPrecise Antibodies Ltd.  , an AI-driven biotherapeutic research and technology company, is pleased to announce the appointment of Kristin Taylor as Chief Financial Officer, effective immediately. Ms. Taylor has been serving as Interim CFO since September 19th, 2023, and now transitions into the role on a permanent basis.\"We are thrilled to welcome Kristin to ImmunoPrecise as our new CFO,\" said Jennifer Bath, CEO of IPA. \"Her extensive experience and proven track record in financial leadership will be invaluable as we continue to drive our growth and strategic initiatives forward. Her performance during her interim tenure has been exemplary, and we are confident in her ability to lead our financial operations.\"","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9NTMq_6UcVa8gfQQZYgp4Q--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/1af22fd2f3274d33f18cb02286fb6362","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9NTMq_6UcVa8gfQQZYgp4Q--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/1af22fd2f3274d33f18cb02286fb6362"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/immunoprecise-appoints-kristin-taylor-chief-120100458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2446666826","title":"ImmunoPrecise Antibodies Unit, PGxAI to Develop AI Model to Predict Treatment Responses","url":"https://stock-news.laohu8.com/highlight/detail?id=2446666826","media":"MT Newswires Live","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446666826?lang=en_us&edition=fundamental","pubTime":"2024-06-26 00:12","pubTimestamp":1719331968,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies  said Tuesday its BioStrand unit is partnering with PGxAI to create an adaptive artificial intelligence model to predict patient responses to drugs, transforming personalized medicine.Financial details of the partnership weren't disclosed.PGxAI will utilize BioStrand's foundation AI model LENSai to develop an AI model for pharmacogenomics, the study of how genetic variations affect drug response, ImmunoPrecise said.Shares of ImmunoPrecise were up 3% in recent trading.Price: 1.03, Change: +0.03, Percent Change: +3.00","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2446171298","title":"ImmunoPrecise Advances Personalized Medicine with AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2446171298","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446171298?lang=en_us&edition=fundamental","pubTime":"2024-06-25 19:50","pubTimestamp":1719316206,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies Ltd.’s subsidiary BioStrand is collaborating with PGxAI to develop ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immunoprecise-advances-personalized-medicine-with-ai?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immunoprecise-advances-personalized-medicine-with-ai?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","IPA"],"gpt_icon":0},{"id":"2446819142","title":"BRIEF-Ipa’S Subsidiary Biostrand And Pgxai Announce Strategic Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2446819142","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446819142?lang=en_us&edition=fundamental","pubTime":"2024-06-25 19:09","pubTimestamp":1719313778,"startTime":"0","endTime":"0","summary":"June 25  - Immunoprecise Antibodies Ltd :   * IPA’S SUBSIDIARY BIOSTRAND AND PGXAI ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP FIRST-IN-CLASS AI MODEL FOR PHARMACOGENOMICS RECOMMENDATIONS USING LENSAISource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA"],"gpt_icon":0},{"id":"2446880811","title":"IPA’s Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™","url":"https://stock-news.laohu8.com/highlight/detail?id=2446880811","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446880811?lang=en_us&edition=fundamental","pubTime":"2024-06-25 19:02","pubTimestamp":1719313320,"startTime":"0","endTime":"0","summary":"VICTORIA, British Columbia, June 25, 2024----ImmunoPrecise Antibodies Ltd.  , an AI-driven biotherapeutic research and technology company, today announced that its subsidiary, BioStrand, is collaborating with PGxAI to leverage BioStrand's patented Foundation AI Model, LENSai. This collaboration advances the precision medicine field of pharmacogenomics and supports LENSai Application Programming Interface  commercial rollout through expanding LENSai features and market reach.Pharmacogenomics, the study of how genetic variations affect drug response, is integral to IPA’s goal to efficiently create tailored therapies and improve patient outcomes. The vast amount of genetic data has historically been difficult for researchers to access, manage, and interpret. LENSai was built to address that challenge through its unique ability to analyze Large Language Models simultaneously with many disparate forms of research and patient data. LENSai was recently made available by BioStrand to certain c","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VqtsBMw7eCnCPVJsHBY_qA--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f11d56becce812eb4cb2458a4510902c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VqtsBMw7eCnCPVJsHBY_qA--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f11d56becce812eb4cb2458a4510902c"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ipa-subsidiary-biostrand-pgxai-announce-110200083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IPA"],"gpt_icon":0},{"id":"2442153072","title":"BioStrand Wins 2024 Impact Award for Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2442153072","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2442153072?lang=en_us&edition=fundamental","pubTime":"2024-06-12 19:48","pubTimestamp":1718192916,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies Ltd. has announced that its subsidiary BioStrand received the 2024 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biostrand-wins-2024-impact-award-for-innovation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biostrand-wins-2024-impact-award-for-innovation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2442532016","title":"ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2442532016","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2442532016?lang=en_us&edition=fundamental","pubTime":"2024-06-12 19:00","pubTimestamp":1718190000,"startTime":"0","endTime":"0","summary":"VICTORIA, British Columbia, June 12, 2024----ImmunoPrecise Antibodies Ltd.  , a leader in AI-driven biotherapeutic research and technology, today announces that its subsidiary, BioStrand, has been honored with the prestigious 2024 Impact Award, sponsored by InterSystems. This recognition highlights BioStrand’s groundbreaking work in biotherapeutic research, which has made a significant impact and set a new standard for innovation in the industry.The 2024 Impact Award acknowledges BioStrand’s innovative LENSai technology, selected from over 1,000 client projects for its remarkable contributions. The selection committee, chaired by Professor Roberto Zicari, identified BioStrand’s work based on three key criteria:. Sets an example: BioStrand’s achievements serve as a benchmark for other organizations, demonstrating excellence in innovation.The award celebration will take place today, from 10:30-11:00 AM ET, during a personalized award presentation session. The event offers an additional e","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1duJkLb5SSmQQuEwAsQRag--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b47a3f65569cfdc5e540676e215036ba","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1duJkLb5SSmQQuEwAsQRag--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b47a3f65569cfdc5e540676e215036ba"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/immunoprecise-antibodies-ltd-subsidiary-biostrand-110000744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","IPA"],"gpt_icon":0},{"id":"2442845186","title":"BioStrand Unveils Innovative AI Drug Discovery Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2442845186","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2442845186?lang=en_us&edition=fundamental","pubTime":"2024-06-10 19:53","pubTimestamp":1718020434,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies subsidiary, BioStrand, has launched a new AI-driven software, LENSa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biostrand-unveils-innovative-ai-drug-discovery-software?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biostrand-unveils-innovative-ai-drug-discovery-software?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","IPA"],"gpt_icon":0},{"id":"2442987843","title":"BioStrand, ImmunoPrecise Antibodies’ Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2442987843","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2442987843?lang=en_us&edition=fundamental","pubTime":"2024-06-10 19:15","pubTimestamp":1718018100,"startTime":"0","endTime":"0","summary":"-BioStrand now offers a Customizable Application Programming Interface  with its new software offering, LENSai API, featuring the ability to integrate sizable databases and electronic health records with large language models.IPA, the #1 ranked contract research organization by Roots Analysis2, serves 19 of the top 20 global pharmaceutical companies and over 600 clients in the pharmaceutical and biotech industries. Leveraging feedback from these long-term relationships, the development of this AI-driven software is in direct response to meeting ongoing industry pain points and needs. These new software capabilities demonstrate innovation by combining BioStrand’s patented LENSai technology with electronic health records through a customizable interface to enable unprecedented research and drug discovery capabilities.Dr. Dirk Van Hyfte stated, \"We have received significant interest in our new technology from large healthcare, pharmaceutical, and technology companies. They are keen on acc","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5uur9C_MGVU8SKSnfVIc8g--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/fa7d1ae259324fe3ae5cf7f0cac6df79","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5uur9C_MGVU8SKSnfVIc8g--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/fa7d1ae259324fe3ae5cf7f0cac6df79"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biostrand-immunoprecise-antibodies-subsidiary-announces-111500689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4535","BK4121","BK4551","TILE","BK4023","IPA","BK4503","API","BK4143"],"gpt_icon":0},{"id":"2441256030","title":"Marcus & Millichap’s IPA Capital Markets secures $72M refinancing for a project in Nebraska","url":"https://stock-news.laohu8.com/highlight/detail?id=2441256030","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2441256030?lang=en_us&edition=fundamental","pubTime":"2024-06-07 16:37","pubTimestamp":1717749425,"startTime":"0","endTime":"0","summary":"IPA Capital Markets, a division ofMarcus & Millichap announced a $72.24M refinance ofLa Vista City Centre, a growing multifamily, office and retail development inLa Vista, Nebraska.Terms of the seven-year loan include full-term interest-only at cost of funds plus 1.75% and a loan-to-value of 70%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4113946-marcus-millichaps-ipa-capital-markets-secures-72m-refinancing-for-a-project-in-nebraska","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["MMI","IE00B19Z6F94.USD","BK4079","BK4121","IPA"],"gpt_icon":0},{"id":"2441750747","title":"Marcus & Millichap’s IPA Capital Markets Division Arranges $72 Million Refinancing for Mixed-Use Development in Omaha MSA","url":"https://stock-news.laohu8.com/highlight/detail?id=2441750747","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2441750747?lang=en_us&edition=fundamental","pubTime":"2024-06-07 06:18","pubTimestamp":1717712280,"startTime":"0","endTime":"0","summary":"LA VISTA, Neb., June 06, 2024----IPA Capital Markets, a division of Marcus & Millichap , specializing in capital markets services for major private and institutional clients, announced the $72.24 million refinance of La Vista City Centre, a growing master-planned multifamily, office and retail development in La Vista, Nebraska.Frank Montalto, IPA Capital Markets managing director based in the firm’s Chicago office, secured the financing on behalf of City+Ventures, a Nebraska-based investment and development company that partnered with the City of La Vista beginning in 2015 for the development of the community.La Vista City Centre features the Vivere Apartments complex consisting of 392 luxury units ranging from studios to two bedrooms, 32,878 square feet of retail space, and 64,883 square feet of office space. Located adjacent to the Vivere Apartments is The Astro, an indoor and outdoor music venue, and a 34-acre park.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/prRp79KeOe0dwvXLdHmGRg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/aae49f161e0cbd639c55b1a29c5fa9ab","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/prRp79KeOe0dwvXLdHmGRg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/aae49f161e0cbd639c55b1a29c5fa9ab"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/marcus-millichap-ipa-capital-markets-221800385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2125909759.SGD","LU0757428866.USD","LU1923622291.USD","BK4121","LU1815336091.USD","BK4143","BK4079","IPA","LU0053671581.USD","LU2125909916.SGD","MSA","MMI","IE00B19Z6F94.USD"],"gpt_icon":0},{"id":"2441254798","title":"Marcus & Millichap’s Institutional Property Advisors Brokers $62 Million North Hollywood Multifamily Asset Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2441254798","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2441254798?lang=en_us&edition=fundamental","pubTime":"2024-06-05 02:45","pubTimestamp":1717526700,"startTime":"0","endTime":"0","summary":"LOS ANGELES, June 04, 2024----Institutional Property Advisors , a division of Marcus & Millichap , announced today the sale of AVA North Hollywood, a 156-unit multifamily property with 11,000 square feet of ground floor retail in the NoHo Arts District of Los Angeles, California. The $62.1 million sales price represents $393,077 per unit.\"By highlighting the opportunity to invest in a market that is in the early stages of benefiting from increasing demand and strong rent growth, we attracted significant interest,\" said Kevin Green, IPA executive managing director investments. \"After substantial development in the submarket pre-COVID that was met with positive absorption but muted rent growth, the area is starting to hit its stride.\" Green and IPA’s Joseph Grabiec and Gregory Harris represented the seller, AvalonBay Communities Inc., and procured the buyer, Prime Residential. \"We garnered over 20 offers on the property during the marketing process,\" said Grabiec. \"This strong interest r","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/2vzJVbO2OeMtlQfdO.BcdQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/d3cfef13bfa308a0671c93b8b01a8f8a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/2vzJVbO2OeMtlQfdO.BcdQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/d3cfef13bfa308a0671c93b8b01a8f8a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/marcus-millichap-institutional-property-advisors-184500921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MMI","IPA","BK4079","BK4121","IE00B19Z6F94.USD"],"gpt_icon":0},{"id":"2440282325","title":"BioStrand Leads Innovation in Precision Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2440282325","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2440282325?lang=en_us&edition=fundamental","pubTime":"2024-06-04 19:53","pubTimestamp":1717502031,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies Ltd.’s subsidiary BioStrand is revolutionizing drug discovery by ap...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biostrand-leads-innovation-in-precision-medicine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biostrand-leads-innovation-in-precision-medicine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2440828940","title":"IPA’s Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2440828940","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2440828940?lang=en_us&edition=fundamental","pubTime":"2024-06-04 19:00","pubTimestamp":1717498800,"startTime":"0","endTime":"0","summary":"Dirk Van Hyfte MD, PhD, Head of Technology, IPA, to present live demonstration at the InterSystems Global Summit 2024 June 9-12, 2024 - National Harbor, Maryland. VICTORIA, British Columbia, June 04, 2024----IPA   , an artificial intelligence-driven biotherapeutic research and technology company, today announced that its Belgian subsidiary, BioStrand, is leveraging their patented Foundation AI Model, LENSai, by applying advanced Large Language Models  to capture real world data from Electronic Health Records . LENSai significantly enhances the analysis and integration of EHR data, enabling the integrated use of real-world data and evidence in drug discovery and the development of precision medicines.\"IPA's BioStrand group continues to innovate. This model has the potential of dramatically simplifying the connection between real-world evidence and therapeutic discovery and development.\" said Jeff Fried, Director of Platform Strategy & Innovation at InterSystems. \"We're proud that they a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dxEHMTylP6p8NoeFAVfyyA--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/72905d5b048e9cc32bf25412c26bc1c7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dxEHMTylP6p8NoeFAVfyyA--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/72905d5b048e9cc32bf25412c26bc1c7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ipa-subsidiary-biostrand-announces-advanced-110000858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0031619046.USD","BK4121","IE00B19Z4B17.USD","IE00B66KJ199.SGD","AEIS","IE00B7SZL793.SGD","IPA","BK4157"],"gpt_icon":0},{"id":"2437486008","title":"$146.5 Million Inland Empire Multifamily Sale Closed By Marcus & Millichap’s Institutional Property Advisors Division","url":"https://stock-news.laohu8.com/highlight/detail?id=2437486008","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2437486008?lang=en_us&edition=fundamental","pubTime":"2024-05-21 02:30","pubTimestamp":1716229800,"startTime":"0","endTime":"0","summary":"MURRIETA, Calif., May 20, 2024----Institutional Property Advisors , a division of Marcus & Millichap , announced the sale of Silverado Apartment Homes, a 492-unit multifamily property in Murrieta, California. The property sold for $146.5 million, which equates to $297,764 per unit.\"Silverado presented a unique opportunity to acquire a newer vintage Inland Empire asset with substantial upside in a burgeoning submarket with strong fundamentals,\" said Kevin Green, IPA executive managing director investments. \"Our controlled process was met with a positive response and yielded a highly competitive sales environment. The opportunity was bolstered by assumable financing, approximately 300 basis points below today’s rates. The acquisition gives the buyer a sizeable footprint in a strong market.\" Green and IPA’s Joseph Grabiec and Gregory Harris represented the seller, Realty Center Management, Inc., and procured the buyer, Bell Partners.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VhmbsvkgoEzwCTyafTzeKQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/185106d002da4ce99460411af7e9d5a6","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VhmbsvkgoEzwCTyafTzeKQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/185106d002da4ce99460411af7e9d5a6"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/146-5-million-inland-empire-183000343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MMI","IE00B19Z6F94.USD","IPA","BK4079","BK4121"],"gpt_icon":0},{"id":"2437483216","title":"ExxonMobil (XOM), Pertamina Progress on CCS Hub in Indonesia","url":"https://stock-news.laohu8.com/highlight/detail?id=2437483216","media":"Zacks","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2437483216?lang=en_us&edition=fundamental","pubTime":"2024-05-21 00:08","pubTimestamp":1716221280,"startTime":"0","endTime":"0","summary":"Exxon Mobil CorporationXOM, in partnership with Indonesian state-owned oil company Pertamina, has embarked on an appraisal drilling project for a carbon capture and storage  hub in Indonesia.The initiative, announced during the Indonesia Petroleum Association  annual conference, marks a pivotal step in utilizing the nation's depleted oil and gas reservoirs, and saline aquifers for carbon dioxide storage.The project, known as the Asri Basin Project CCS hub, is located in Pertamina’s Offshore South East Sumatra block. Per a joint study by Pertamina and ExxonMobil, the basin could store up to three gigatons of carbon dioxide, potentially requiring an investment of $2 billion.The venture aligns with Indonesia's strategy to combat climate change by repurposing its geological formations to sequester carbon effectively. In a legislative move supportive of this environmental strategy, Indonesia has recently permitted CCS operators to reserve 30% of their storage capacity for imported carbon, f","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xZ9wY7_RPTPrYPVqTYHW9g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b81ac34444d94825c1ca7ea33d2f8831","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xZ9wY7_RPTPrYPVqTYHW9g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b81ac34444d94825c1ca7ea33d2f8831"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exxonmobil-xom-pertamina-progress-ccs-160800735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","BK4201","CCS","LU0320765646.SGD","LU1267930813.SGD","EC","LU0068578508.USD","SG9999015358.SGD","LU0170899867.USD","SM","LU1066051498.USD","BK4550","HUBG","LU0985489474.SGD","IE00B1XK9C88.USD","LU1839511570.USD","IPA","IE00B7SZL793.SGD","SG9999014567.USD","LU0795875169.SGD","LU0300736492.USD","MPC","LU0122376428.USD","BK4516","LU0456854461.SGD","SG9999002232.USD","LU0795875086.SGD","XOM","SG9999014559.SGD","LU1074936037.SGD","LU2602419157.SGD","LU1150488135.SGD","SG9999015341.SGD","SG9999002224.SGD","LU2347655156.SGD","LU1150488218.USD","PRGS","BK4121","LU0098860793.USD","LU1732799900.SGD","LU1732800096.USD","IE00B66KJ199.SGD","LU0300736062.USD","IE0031619046.USD","LU0266512127.USD","IE00BWXC8680.SGD","LU0433182093.SGD","LU0878866978.SGD","SG9999014575.USD","LU0889566641.SGD"],"gpt_icon":0},{"id":"2436947738","title":"Marcus & Millichap Expands Leading Talent Acquisitions Across North America","url":"https://stock-news.laohu8.com/highlight/detail?id=2436947738","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2436947738?lang=en_us&edition=fundamental","pubTime":"2024-05-18 03:07","pubTimestamp":1715972820,"startTime":"0","endTime":"0","summary":"CALABASAS, Calif., May 17, 2024----Marcus & Millichap , a leading commercial real estate  brokerage firm specializing in investment sales, financing, research and advisory services, recognized as a Best Place to Work two consecutive years, continues to build its senior-level broker and financing professional hiring momentum across its Institutional Property Advisors , multi housing, retail, and capital markets divisions. The firm also expanded its IPA financing intermediary services to investors in Canada, providing more CRE acquisition opportunities to Canadian investors.Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. As of December 31, 2023, the company h","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1oV0Co7Kf9h.sHVLLBHnJQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/5f5dfe4a91a4e74ecc7b6d633735878b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1oV0Co7Kf9h.sHVLLBHnJQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/5f5dfe4a91a4e74ecc7b6d633735878b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/marcus-millichap-expands-leading-talent-190700087.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z6F94.USD","BK4121","IPA","BK4079","MMI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunoprecise.com","stockEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":-0.0099},{"period":"3month","weight":-0.3056},{"period":"6month","weight":-0.3197},{"period":"1year","weight":-0.67},{"period":"ytd","weight":-0.4152}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0698},{"period":"6month","weight":0.1853},{"period":"1year","weight":0.2615},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.04828},{"month":2,"riseRate":0.25,"avgChangeRate":-0.118539},{"month":3,"riseRate":0.25,"avgChangeRate":-0.179314},{"month":4,"riseRate":0.25,"avgChangeRate":-0.038624},{"month":5,"riseRate":0.5,"avgChangeRate":-0.017976},{"month":6,"riseRate":0,"avgChangeRate":-0.179973},{"month":7,"riseRate":0.5,"avgChangeRate":0.011908},{"month":8,"riseRate":0.666667,"avgChangeRate":0.043876},{"month":9,"riseRate":0,"avgChangeRate":-0.146778},{"month":10,"riseRate":1,"avgChangeRate":0.186894},{"month":11,"riseRate":0,"avgChangeRate":-0.137051},{"month":12,"riseRate":0.666667,"avgChangeRate":0.012351}],"exchange":"NASDAQ","name":"Immunoprecise Antibodies Ltd","nameEN":"Immunoprecise Antibodies Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunoprecise Antibodies Ltd(IPA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Immunoprecise Antibodies Ltd(IPA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Immunoprecise Antibodies Ltd,IPA,Immunoprecise Antibodies Ltd股票,Immunoprecise Antibodies Ltd股票老虎,Immunoprecise Antibodies Ltd股票老虎国际,Immunoprecise Antibodies Ltd行情,Immunoprecise Antibodies Ltd股票行情,Immunoprecise Antibodies Ltd股价,Immunoprecise Antibodies Ltd股市,Immunoprecise Antibodies Ltd股票价格,Immunoprecise Antibodies Ltd股票交易,Immunoprecise Antibodies Ltd股票购买,Immunoprecise Antibodies Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunoprecise Antibodies Ltd(IPA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Immunoprecise Antibodies Ltd(IPA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction